|
|
|
|
| LEADER |
04947nam a2200733 4500 |
| 001 |
ocn867001313 |
| 003 |
OCoLC |
| 005 |
20170124070005.1 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
131230s2014 enk ob 001 0 eng |
| 010 |
|
|
|a 2013051081
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d YDX
|d N$T
|d YDXCP
|d DG1
|d IDEBK
|d CUS
|d CDX
|d COO
|d OCLCF
|d E7B
|d EBLCP
|d OCLCQ
|d DEBBG
|d GrThAP
|
| 066 |
|
|
|c (S
|
| 019 |
|
|
|a 928632128
|
| 020 |
|
|
|a 9781118683149 (ePub)
|
| 020 |
|
|
|a 1118683145 (ePub)
|
| 020 |
|
|
|a 9781118683842 (Adobe PDF)
|
| 020 |
|
|
|a 1118683846 (Adobe PDF)
|
| 020 |
|
|
|z 9781119950608 (hardback)
|
| 020 |
|
|
|a 9781118683033
|
| 020 |
|
|
|a 111868303X
|
| 020 |
|
|
|a 1119950600
|
| 020 |
|
|
|a 9781119950608
|
| 020 |
|
|
|a 9781306546980
|
| 020 |
|
|
|a 1306546982
|
| 029 |
1 |
|
|a NZ1
|b 15497399
|
| 029 |
1 |
|
|a NZ1
|b 15906664
|
| 029 |
1 |
|
|a CHVBK
|b 33409531X
|
| 029 |
1 |
|
|a CHBIS
|b 010442021
|
| 029 |
1 |
|
|a DEBBG
|b BV043396448
|
| 035 |
|
|
|a (OCoLC)867001313
|z (OCoLC)928632128
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RS431.P38
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 615.1/9
|2 23
|
| 084 |
|
|
|a SCI013050
|2 bisacsh
|
| 049 |
|
|
|a MAIN
|
| 100 |
1 |
|
|a Trabocchi, Andrea,
|e author.
|
| 245 |
1 |
0 |
|a Peptidomimetics in organic and medicinal chemistry /
|c Dr. Andrea Trabocchi and Professor Antonio Guarna.
|
| 264 |
|
1 |
|a Chichester, West Sussex, UK ;
|a Hoboken, NJ :
|b John Wiley & Sons Inc.,
|c 2014.
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a computer
|2 rdamedia
|
| 338 |
|
|
|a online resource
|2 rdacarrier
|
| 520 |
|
|
|a "A peptidomimetic is a small protein-like chain designed to mimic a peptide with adjusted molecular properties such as enhanced stability or biological activity. It is a very powerful approach for the generation of small-molecule-based drugs as enzyme inhibitors or receptor ligands.Peptidomimetics in Organic and Medicinal Chemistry outlines the concepts and synthetic strategies underlying the building of bioactive compounds of a peptidomimetic nature. Topics covered include the chemistry of unnatural amino acids, peptide- and scaffold-based peptidomimetics, amino acid-side chain isosteres, backbone isosteres, dipeptide isosteres, beta-turn peptidomimetics, proline-mimetics as turn inducers, cyclic scaffolds, amino acid surrogates, and scaffolds for combinatorial chemistry of peptidomimetics. Case studies in the hit-to-lead process, such as the development of integrin ligands and thrombin inhibitors, illustrate the successful application of peptidomimetics in drug discovery"--
|c Provided by publisher.
|
| 520 |
|
|
|a "Peptidomimetics in Organic and Medicinal Chemistry outlines the concepts and synthetic strategies underlying the building of bioactive compounds of a peptidomimetic nature"--
|c Provided by publisher.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on print version record and CIP data provided by publisher.
|
| 505 |
0 |
|
|a Title Page; Copyright; Dedication; Preface; Abbreviations; Part I: The Basics of Peptidomimetics; Chapter 1: The Basics of Peptidomimetics; 1.1 Introduction; 1.2 Definition and Classification; 1.3 Strategic Approaches to Peptidomimetic Design; 1.4 Successful Examples of Peptidomimetic Drugs; 1.5 Conclusion; References; Chapter 2: Synthetic Approaches towards Peptidomimetic Design; 2.1 Introduction; 2.2 Local Modifications; 2.3 Global Restrictions through Cyclic Peptidomimetics; 2.4 Peptidomimetic Scaffolds; 2.5 Conclusions; References; Part II: Synthetic Methods and Molecules
|
| 505 |
8 |
|
|a Chapter 3: Peptidomimetic Bioisosteres3.1 Introduction; 3.2 Peptide Bond Isosteres; 3.3 Side-Chain Isosteres; 3.4 Dipeptide Isosteres; 3.5 Tripeptide Isosteres; 3.6 Conclusion; References; Chapter 4: Solid-Phase Synthesis and Combinatorial Approaches to Peptidomimetics; 4.1 Introduction; 4.2 Solid-Phase Synthesis of Peptidomimetics; 4.3 Conclusion; References; Chapter 5: Click Chemistry: The Triazole Ring as a Privileged Peptidomimetic Scaffold; 5.1 Introduction; 5.2 Triazole-Containing Peptidomimetics Elaborated through 'Click Chemistry'; 5.3 Relevant Applications in Drug Discovery
|
| 650 |
|
0 |
|a Peptide drugs.
|
| 650 |
|
0 |
|a Proteins
|x Therapeutic use.
|
| 650 |
|
0 |
|a Drugs
|x Design.
|
| 650 |
|
7 |
|a SCIENCE / Chemistry / Physical & Theoretical.
|2 bisacsh
|
| 650 |
|
7 |
|a Drugs
|x Design.
|2 fast
|0 (OCoLC)fst00898790
|
| 650 |
|
7 |
|a Peptide drugs.
|2 fast
|0 (OCoLC)fst01057556
|
| 650 |
|
7 |
|a Proteins
|x Therapeutic use.
|2 fast
|0 (OCoLC)fst01079767
|
| 655 |
|
4 |
|a Electronic books.
|
| 655 |
|
0 |
|a Electronic books.
|
| 700 |
1 |
|
|a Guarna, Antonio,
|e author.
|
| 776 |
0 |
8 |
|i Print version:
|a Trabocchi, Andrea, author.
|t Peptidomimetics in organic and medicinal chemistry
|d Chichester, West Sussex ; Hoboken, NJ : John Wiley & Sons Inc., 2014
|z 9781119950608
|w (DLC) 2013048681
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9781118683033
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|